Landec Corporation (LNDC): Price and Financial Metrics


Landec Corporation (LNDC): $8.76

-0.32 (-3.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LNDC to Watchlist
Sign Up

Industry: Food Makers


Ranked

of

in industry

LNDC POWR Grades

  • LNDC scores best on the Sentiment dimension, with a Sentiment rank ahead of 67.18% of US stocks.
  • The strongest trend for LNDC is in Growth, which has been heading down over the past 177 days.
  • LNDC's current lowest rank is in the Quality metric (where it is better than 12.66% of US stocks).

LNDC Stock Summary

  • LANDEC CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 81.89% of US listed stocks.
  • In terms of twelve month growth in earnings before interest and taxes, LANDEC CORP is reporting a growth rate of 432.03%; that's higher than 95.99% of US stocks.
  • Revenue growth over the past 12 months for LANDEC CORP comes in at -49.09%, a number that bests only 3.71% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to LANDEC CORP, a group of peers worth examining would be AYTU, TEVA, AGFS, XRX, and OBLG.
  • LNDC's SEC filings can be seen here. And to visit LANDEC CORP's official web site, go to www.landec.com.

LNDC Valuation Summary

  • In comparison to the median Consumer Defensive stock, LNDC's price/sales ratio is 55% lower, now standing at 0.9.
  • LNDC's EV/EBIT ratio has moved up 19.7 over the prior 243 months.

Below are key valuation metrics over time for LNDC.

Stock Date P/S P/B P/E EV/EBIT
LNDC 2022-11-09 0.9 2.6 -2.6 -4.6
LNDC 2022-11-08 1.0 2.7 -2.6 -4.7
LNDC 2022-11-07 1.0 2.8 -2.7 -4.8
LNDC 2022-11-04 1.0 2.8 -2.7 -4.8
LNDC 2022-11-03 1.0 2.8 -2.7 -4.8
LNDC 2022-11-02 1.0 2.8 -2.7 -4.8

LNDC Growth Metrics

    Its 5 year cash and equivalents growth rate is now at 1.6%.
  • Its 5 year revenue growth rate is now at 9.93%.
  • The 4 year price growth rate now stands at -27.21%.
Over the past 70 months, LNDC's revenue has gone down $260,013,000.

The table below shows LNDC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 273.549 -26.763 -100.018
2022-06-30 185.786 -24.399 -97.431
2022-03-31 451.187 -20.018 -63.634
2021-12-31 535.895 -7.745 -56.282
2021-09-30 537.307 -1.173 -31.142
2021-06-30 544.161 15.017 -32.665

LNDC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LNDC has a Quality Grade of D, ranking ahead of 13.27% of graded US stocks.
  • LNDC's asset turnover comes in at 1.098 -- ranking 21st of 59 Food Products stocks.
  • FLO, LANC, and TSN are the stocks whose asset turnover ratios are most correlated with LNDC.

The table below shows LNDC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-08-29 1.098 0.154 -0.036
2021-05-30 1.079 0.150 -0.054
2021-02-28 1.090 0.144 -0.096
2020-11-29 1.098 0.141 -0.125
2020-08-30 1.089 0.129 -0.104
2020-05-31 1.075 0.127 -0.086

LNDC Price Target

For more insight on analysts targets of LNDC, see our LNDC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $14.40 Average Broker Recommendation 1.4 (Strong Buy)

LNDC Stock Price Chart Interactive Chart >

Price chart for LNDC

LNDC Price/Volume Stats

Current price $8.76 52-week high $12.04
Prev. close $9.08 52-week low $7.65
Day low $8.71 Volume 72,000
Day high $9.01 Avg. volume 84,032
50-day MA $8.99 Dividend yield N/A
200-day MA $10.11 Market Cap 259.26M

Landec Corporation (LNDC) Company Bio


Landec Corporation designs, develops, manufactures, and markets differentiated products in food and biomedical materials markets. It operates through three segments: Food Products Technology, Food Export, and Hyaluronan-Based Biomaterials. The company was founded in 1986 and is based in Menlo Park, California.


LNDC Latest News Stream


Event/Time News Detail
Loading, please wait...

LNDC Latest Social Stream


Loading social stream, please wait...

View Full LNDC Social Stream

Latest LNDC News From Around the Web

Below are the latest news stories about LANDEC CORP that investors may wish to consider to help them evaluate LNDC as an investment opportunity.

Lifecore Biomedical CEO Hall on Rebranding, New Ticker on Nasdaq

Lifecore Biomedical CEO James G. Hall By Jarrett Banks IPO Edge: Can you give me a short description of what Lifecore does? Lifecore Biomedical is a fully integrated contract development […]

Yahoo | November 15, 2022

Lifecore Biomedical Announces Completion of Corporate Name Change

Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol “LFCR” Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com CHASKA, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has completed its transition to Lifecore Biomedical, including the change of its name from La

Yahoo | November 14, 2022

Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022

CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. (“Lifecore”) and Curation Foods, Inc. (“Curation Foods”), – today announced that Jim Hall, CEO of Landec Corporation & President of Lifecore, and John Morberg, CFO will be hosting a fireside chat at the Stephens Annual Investment Conference in Nashville, TN. The Company will participate

Yahoo | November 10, 2022

Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14

CHASKA, Minn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”) today announced that it expects to effect its previously announced corporate name change to Lifecore Biomedical, Inc. and to cause its common stock to begin trading on Nasdaq under the ticker symbol “LFCR” prior to market open on November 14, 2022. This new ticker symbol will replace the Company’s current ticker symbol “LNDC,” which has been used since its initial public offering in 1

Yahoo | November 1, 2022

Landec: Q1 Earnings Insights

Landec (NASDAQ: LNDC ) reported its Q1 earnings results on Thursday, October 6, 2022 at 07:15 AM. Here''s what investors need to know about the announcement. Earnings Landec missed estimated earnings by 146.15%, reporting an EPS of $-0.32 versus an … Full story available on Benzinga.com

Benzinga | October 6, 2022

Read More 'LNDC' Stories Here

LNDC Price Returns

1-mo N/A
3-mo -9.50%
6-mo -15.61%
1-year -16.17%
3-year -21.79%
5-year -33.38%
YTD N/A
2022 0.00%
2021 2.30%
2020 -4.07%
2019 -4.48%
2018 -6.03%

Continue Researching LNDC

Want to see what other sources are saying about Landec Corp's financials and stock price? Try the links below:

Landec Corp (LNDC) Stock Price | Nasdaq
Landec Corp (LNDC) Stock Quote, History and News - Yahoo Finance
Landec Corp (LNDC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7045 seconds.